Numaferm Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $57.8K

  • Investors
  • 8

Numaferm General Information

Description

Developer of peptide production technology designed to unlock the potential of peptides, pepteins, and proteins as feedstock. The company's technology uses microorganisms to convert simple nutrients to peptides and offers services like peptide development, custom synthesis, and larger-scale production, enabling clients to get help in the discovery and commercial production of peptides.

Contact Information

Website
www.numaferm.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Merowingerplatz 1a
  • 40225 Dusseldorf
  • Germany
+49 0211
Primary Industry
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Merowingerplatz 1a
  • 40225 Dusseldorf
  • Germany
+49 0211

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Numaferm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 23-Oct-2018 $57.8K Completed Generating Revenue
2. Seed Round 11-May-2017 Completed Generating Revenue
1. Grant 01-Oct-2015 Completed Startup
To view Numaferm’s complete valuation and funding history, request access »

Numaferm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of peptide production technology designed to unlock the potential of peptides, pepteins, and proteins as feeds
Biotechnology
Dusseldorf, Germany
18 As of 2025

Hillsborough, NJ

Trumbull, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Numaferm Competitors (15)

One of Numaferm’s 15 competitors is LifeTein, LLC, a Corporation company based in Hillsborough, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LifeTein, LLC Corporation Hillsborough, NJ
ARVYS Proteins Corporation Trumbull, CT
Proteintech Corporation Rosemont, IL
Eurofins Genomics Europe Shared Services Accelerator/Incubator Backed Ebersberg, Germany
ProSci (Poway) Private Equity-Backed Poway, CA
You’re viewing 5 of 15 competitors. Get the full list »

Numaferm Patents

  • 28

    Total Documents Applications and Grants

  • Total Patents Families

  • 17

    Granted

  • 7

    Pending

  • Expiring in next 12 mo

Numaferm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4339202-A1 Fusion proteins comprising gg repeat sequences ii Inactive 16-Sep-2022
EP-4321618-A1 Variants of tev protease and uses thereof Inactive 09-Aug-2022
EP-4569098-A1 Variants of tev protease and uses thereof Pending 09-Aug-2022
EP-4308704-A1 Fusion proteins comprising gg repeat sequences Pending 18-Mar-2021
US-20240228553-A1 Fusion proteins comprising gg repeat sequences Pending 18-Mar-2021 C07K14/245
To view Numaferm’s complete patent history, request access »

Numaferm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Numaferm Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon 2020 Government
Bundesministerium für Bildung und Forschung Government Minority
Angel (individual) Minority
European Investment Fund Fund of Funds Minority
Evonik Venture Capital Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Numaferm FAQs

  • When was Numaferm founded?

    Numaferm was founded in 2015.

  • Where is Numaferm headquartered?

    Numaferm is headquartered in Dusseldorf, Germany.

  • What is the size of Numaferm?

    Numaferm has 18 total employees.

  • What industry is Numaferm in?

    Numaferm’s primary industry is Biotechnology.

  • Is Numaferm a private or public company?

    Numaferm is a Private company.

  • What is Numaferm’s current revenue?

    The current revenue for Numaferm is .

  • Who are Numaferm’s investors?

    Horizon 2020, Bundesministerium für Bildung und Forschung, , European Investment Fund, and Evonik Venture Capital are 5 of 8 investors who have invested in Numaferm.

  • Who are Numaferm’s competitors?

    LifeTein, LLC, ARVYS Proteins, Proteintech, Eurofins Genomics Europe Shared Services, and ProSci (Poway) are some of the 15 competitors of Numaferm.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »